Sexual HIV transmission and antiretroviral therapy: A prospective cohort study of behavioral risk factors among men and women living with HIV/AIDS

Annals of Behavioral Medicine

Volumn 42, Issue 1, 2011, Pages 111-119

  Kalichman, Seth C ^a   Cherry, Chauncey ^a   White, Denise ^a   Jones, Miche'L ^a   Grebler, Tamar ^a   Kalichman, Moira O ^a   Detorio, Mervi ^b   Caliendo, Angela M ^b   Schinazi, Raymond F ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HIV prevention; HIV treatment for prevention; Positive prevention; Sexual risk behavior; Test and treat

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLOOD; COHORT ANALYSIS; DISEASE TRANSMISSION; DRINKING BEHAVIOR; FEMALE; HEALTH BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PATIENT COMPLIANCE; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RISK FACTOR; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; STATISTICS; UNSAFE SEX;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALCOHOL DRINKING; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; FEMALE; HEALTH BEHAVIOR; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; MEDICATION ADHERENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; UNSAFE SEX;

EID: 79960566377     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12160-011-9271-3     Document Type: Article

References (42)

1. SC Kalichman 2008 Time to take stock in HIV/AIDS prevention AIDS Behav 12 3 333 334 18360742 10.1007/s10461-008-9377-1
2. Grant RM, Lama JR, Anderson PL et al., Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. New Eng J Med, 2010; epub ahead of print, November 23, 2010.
3. AD Kashuba JR Dyer L Kramer R Raasch J Eron M Cohen 1999 Antiretroviral-drug concentrations in semen: implications for sexual transmission of human immunodeficiency virus type 1 Antimicrob Agents Chemotherther 43 8 1817 1826 1:CAS:528:DyaK1MXltVeksrw%3D (Pubitemid 29395171)
4. D Donnell JM Baeteb J Kiarie K Thomas W Stevens C Cohen J MCIntyre J Lingappa C Celum 2010 Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis Lancet 375 2092 2098 20537376 10.1016/S0140-6736(10)60705-2
5. TC Quinn M Wawer MB Sewankambo D Serwadda C Li F Wabwire-Mangen, et al. 2000 Viral load and heterosexual transmission of human immunodeficiency virus type 1 N Engl J Med 342 921 929 10738050 10.1056/NEJM200003303421303 1:STN:280:DC%2BD3c7otlWjsA%3D%3D (Pubitemid 30177052)
6. RM Granich CF Gilks C Dye K DeCock B Williams 2009 Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model Lancet 373 9657 48 57 19038438 10.1016/S0140-6736(08)61697-9
7. VD Lima RS Hogg JS Montaner 2010 Expanding HAART treatment to all currently eligible individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada PLoS ONE 5 6 e10991 20539817 10.1371/journal.pone.0010991
8. P Vernazza B Hirschel E Bernasconi M Flepp 2008 HIV-positive individuals without additional sexually transmitted diseases (STD) and on effective anti-retroviral therapy are sexually non-infectious Bull médecins suisses 89 5
9. B Hasse B Ledergerber B Hischel P Vernazza T Glass A Jeannin, et al. 2010 Frequency and determinants of unprotected sex among HIV-infected persons: the swiss HIV cohort study Clin Inf Dis 51 11 1314 1322 10.1086/656809
10. KM De Cock, et al. 2009 Can antiretroviral therapy eliminate HIV transmission? Lancet 373 9657 7 9 19038440 10.1016/S0140-6736(08)61732-8
11. CW Dieffenbach A Fauci 2009 Universal voluntary testing and treatment for prevention of HIV transmission JAMA 301 22 2380 2382 19509386 10.1001/jama.2009.828 1:CAS:528:DC%2BD1MXntFertrs%3D
12. GP Garnett R Baggaley 2009 Treating our way out of the HIV pandemic: could we, would we, should we? Lancet 373 9657 9 11 19038439 10.1016/S0140-6736(08)61698-0
13. B Wagner S Blower 2010 Costs of eliminating HIV in South Africa have been underestimated Lancet 376 9745 953 954 20851250 10.1016/S0140-6736(10)61442-0
14. B Wagner J Kahn S Blower 2010 Should we try to eliminate HIV epidemics by using a 'Test and Treat' strategy? AIDS 24 5 775 776 20177359 10.1097/QAD.0b013e3283366782
15. C Celum, et al. 2010 Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2 New Eng J Med 362 5 427 439 20089951 10.1056/NEJMoa0904849 1:CAS:528:DC%2BC3cXhvVams70%3D
16. MS Cohen, et al. 1997 Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1 Lancet 349 1868 1873 9217758 10.1016/S0140-6736(97)02190-9 1:STN:280:DyaK2szmtVOqtw%3D%3D (Pubitemid 27270120)
17. EJ Mills, et al. 2006 Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis JAMA 296 6 679 690 16896111 10.1001/jama.296.6.679 1:CAS:528:DC%2BD28XotFagtbY%3D (Pubitemid 44200639)
18. SC Kalichman L Eaton C Cherry, et al. 2010 Sexually transmitted infections and infectiousness beliefs among people living with HIV/AIDS: implications for HIV treatment as prevention HIV Med 11 502 509 20201976 1:STN:280:DC%2BC3cjjtlGgtQ%3D%3D
19. PA Shuper, et al. 2009 Alcohol as a correlate of unprotected sexual behavior among people living with HIV/AIDS: review and meta-analysis AIDS Behav 13 6 1021 1036 19618261 10.1007/s10461-009-9589-z
20. KP Theall, et al. 2007 Alcohol consumption, ART usage and high-risk sex among women infected with HIV AIDS Behav 11 2 205 215 16897350 10.1007/s10461-006-9159-6 1:STN:280:DC%2BD2s7htlektQ%3D%3D
21. KR Amico, et al. 2009 The information-motivation-behavioral skills model of ART adherence in a deep south HIV+ clinic sample AIDS Behav 13 1 66 75 17876697 10.1007/s10461-007-9311-y
22. CS Hendershot, et al. 2009 Alcohol use and antiretroviral adherence: review and meta-analysis JAIDS 52 2 180 202 19668086 10.1097/QAI. 0b013e3181b18b6e
23. D Baliunas, et al. 2010 Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis Internat J Public Health 55 3 159 166 10.1007/s00038-009-0095-x
24. SC Kalichman D Rompa 2003 HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy Sex Transm Inf 79 1 59 61 10.1136/sti.79.1.59 1:STN:280:DC%2BD3s%2Fms12gsA%3D%3D (Pubitemid 36237829)
25. C Diamond, et al. 2005 Use of and adherence to antiretroviral therapy is associated with decreased sexual risk behavior in HIV clinic patients JAIDS 39 211 218 15905739 (Pubitemid 40741121)
26. SC Kalichman 2008 Co-occurrence of treatment nonadherence and continued HIV transmission risk behaviors: implications for positive prevention interventions Psychosom Med 70 5 593 597 18519882 10.1097/PSY.0b013e3181773bce
27. SC Kalichman D Rompa M Cage 2000 Distinguishing between overlapping somatic symptoms of depression and HIV disease in people living with HIV-AIDS J Nerv Ment Dis 188 10 662 670 11048815 10.1097/00005053-200010000-00004 1:STN:280:DC%2BD3crgtFersQ%3D%3D
28. RF Baggaley RG White MC Boily 2010 HIV transmission risk through anal intercourse: systematic review, meta-analysis and implications for HIV prevention Internat J Epid 39 4 1048 1063 10.1093/ije/dyq057
29. LE Napper D Fisher G Reynolds M Johnson 2010 HIV risk behavior self-report reliability at different recall periods AIDS Behav 14 15 61 10.1007/s10461-009-9575-5
30. DR Bangsberg, et al. 2001 Comparing objective measures of adherence to HIV antiretroviral therapy: electronic medication monitors and unannounced pill counts AIDS Behav 5 275 281 10.1023/A:1011396711486 (Pubitemid 35364540)
31. SC Kalichman, et al. 2008 Monitoring Antiretroviral adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity HIV Clin Trials 9 298 308 18977718 10.1310/hct0905-298
32. SC Kalichman, et al. 2007 Adherence to antiretroviral therapy assessed by unannounced pill counts conducted by telephone J Gen Intern Med 22 1003 1006 17390095 10.1007/s11606-007-0171-y (Pubitemid 46878598)
33. R Granich, et al. 2010 Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update Cur Opin HIV AIDS 5 4 298 304 10.1097/COH.0b013e32833a6c32
34. F Engsig, et al. 2010 Risk of high-level viraemia in HIV-infected patients on successful antiretroviral treatment for more than 6 months HIV Med 11 457 461 20158527 1:STN:280:DC%2BC3cnnslansQ%3D%3D
35. M Das, et al. 2010 Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco PLoS ONE 5 6 e11068 20548786 10.1371/journal.pone.0011068
36. SG Deeks, et al. 2009 Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America Clin Infect Dis 49 10 1582 1590 19845473 10.1086/644768
37. JJ Parienti, et al. 2008 Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels PLoS ONE 3 7 e2783 18665246 10.1371/journal.pone.0002783
38. MS Cohen CL Gay 2010 Treatment to prevent transmission of HIV-1 Clin Infect Dis 50 Suppl 3 S85 S95 20397961 10.1086/651478
39. LF Johnson DA Lewis 2008 The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis Sex Transm Dis 35 11 946 959 18685546 10.1097/OLQ.0b013e3181812d15
40. JM Simoni, et al. 2006 Efficacy of interventions in improving highly active antiretroviral therapy adherence and HIV-1 RNA viral load. A meta-analytic review of randomized controlled trials JAIDS 43 Suppl 1 S23 S35 17133201 10.1097/01.qai.0000248342.05438.52 (Pubitemid 44885639)
41. N Crepaz, et al. 2006 Do prevention interventions reduce HIV risk behaviours among people living with HIV? A meta-analytic review of controlled trials AIDS 20 2 143 157 16511407 10.1097/01.aids.0000196166.48518.a0
42. BT Johnson, et al. 2009 Behavioral interventions for African Americans to reduce sexual risk of HIV: a meta-analysis of randomized controlled trials JAIDS 51 4 492 501 19436218 10.1097/QAI.0b013e3181a28121